SME Times is powered by   
Search News
Just in:   • Sensex tanks 1,248 points, Nifty slips below 23,100 amid oil price concerns  • Adani Group to invest over Rs 1,00,000 crore in West Bengal by 2035: Gautam Adani  • ASSOCHAM launches TIPS platform to boost trade, investment and exports  • Sensex, Nifty post early losses as global bond yields rise higher  • “Dependable electrical solutions begin with protection, organization, and functional design.”: K Babu 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» Sensex tanks 1,248 points, Nifty slips below 23,100 amid oil price concerns
» Sensex, Nifty post early losses as global bond yields rise higher
» Sensex, Nifty post marginal gains as crude prices drop below $100
» Sensex, Nifty open marginally higher over crude price correction
» Sensex, Nifty post early gains over correction in crude prices
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter